Liu Ta-Chiang, Gao Feng, McGovern Dermot P B, Stappenbeck Thaddeus S
*Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri; †Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri; ‡The F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, and §Medical Genetics Research Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Inflamm Bowel Dis. 2014 Apr;20(4):646-51. doi: 10.1097/01.MIB.0000442838.21040.d7.
We previously demonstrated that morphologic defects of ileal Paneth cells correlate with multiple susceptible genetic variants, the presence of granuloma, and clinical outcome in Crohn's disease. These studies were performed using uninvolved areas of resection specimens. To develop Paneth cell phenotype as a prognostic biomarker in Crohn's disease, further characterization is necessary. Specifically, effects of disease activity, phenotype duration, and the minimal crypt number that would allow for accurate Paneth cell phenotyping are unknown.
We compared Paneth cell phenotypes in (1) 46 cases with paired involved and uninvolved sections; (2) 36 cases with multiple ileal resections over time; (3) "virtual biopsies" by randomly selecting 10 to 60 crypts from 85 surgical cases where 250 crypts had been analyzed; and (4) 26 cases with resection and biopsy performed within 1 year.
In paired resection specimens, the Paneth cell phenotypes in the uninvolved areas correlated with those seen in involved areas (P < 0.0001) and also predicted the presence of granuloma (P = 0.042). Importantly, the Paneth cell phenotype remained stable over time (P < 0.0001). By mathematical analyses, a minimum of 40 crypts was required to generate results equivalent to those using resection specimens. Finally, there was good correlation in Paneth cell phenotypes in biopsy specimens and resection specimens obtained within 1 year (P = 0.0004).
Accurate Paneth cell phenotypes can be assessed using biopsy materials with the caveat that sufficient well-oriented crypts exist in the specimen. This advance will extend the potential clinical application of this novel stratification platform.
我们之前证明,回肠潘氏细胞的形态学缺陷与多种易感基因变异、肉芽肿的存在以及克罗恩病的临床结局相关。这些研究是使用切除标本的未受累区域进行的。为了将潘氏细胞表型发展为克罗恩病的一种预后生物标志物,有必要进行进一步的特征描述。具体而言,疾病活动度、表型持续时间以及能够实现准确潘氏细胞表型分析的最小隐窝数量的影响尚不清楚。
我们比较了以下几种情况下的潘氏细胞表型:(1)46例有配对的受累和未受累切片的病例;(2)36例随时间进行多次回肠切除的病例;(3)通过从85例手术病例中随机选择10至60个隐窝进行“虚拟活检”,这些病例共分析了250个隐窝;(4)26例在1年内进行切除和活检的病例。
在配对的切除标本中,未受累区域的潘氏细胞表型与受累区域的表型相关(P < 0.0001),并且还能预测肉芽肿的存在(P = 0.042)。重要的是,潘氏细胞表型随时间保持稳定(P < 0.0001)。通过数学分析,至少需要40个隐窝才能得出与使用切除标本相当的结果。最后,活检标本和1年内获取的切除标本中的潘氏细胞表型具有良好的相关性(P = 0.0004)。
如果标本中存在足够数量的方向良好的隐窝,活检材料可用于准确评估潘氏细胞表型。这一进展将扩展这一新型分层平台的潜在临床应用。